Axogen Net Income from 2010 to 2026
| AXGN Stock | USD 33.23 0.62 1.90% |
Net Loss | First Reported 1986-09-30 | Previous Quarter 579 K | Current Value 708 K | Quarterly Volatility 3 M |
Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 9.9 M or Total Revenue of 226.2 M, as well as many indicators such as Price To Sales Ratio of 3.33, Dividend Yield of 0.27 or PTB Ratio of 6.0. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
Axogen | Net Income | Build AI portfolio with Axogen Stock |
Evaluating Axogen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Axogen Inc's fundamental strength.
Latest Axogen's Net Income Growth Pattern
Below is the plot of the Net Income of Axogen Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Axogen Inc financial statement analysis. It represents the amount of money remaining after all of Axogen Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Axogen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axogen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (9.96 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Axogen Net Income Regression Statistics
| Arithmetic Mean | (15,877,597) | |
| Geometric Mean | 12,584,932 | |
| Coefficient Of Variation | (52.94) | |
| Mean Deviation | 7,002,505 | |
| Median | (14,411,144) | |
| Standard Deviation | 8,406,221 | |
| Sample Variance | 70.7T | |
| Range | 29.6M | |
| R-Value | (0.35) | |
| Mean Square Error | 66T | |
| R-Squared | 0.12 | |
| Significance | 0.16 | |
| Slope | (587,991) | |
| Total Sum of Squares | 1130.6T |
Axogen Net Income History
Other Fundumenentals of Axogen Inc
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Axogen Net Income component correlations
About Axogen Financial Statements
Axogen investors utilize fundamental indicators, such as Net Income, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -9 M | -9.4 M | |
| Net Loss | -9 M | -9.4 M | |
| Net Loss | -26.1 M | -27.4 M | |
| Net Loss | (0.26) | (0.27) | |
| Net Income Per E B T | 1.15 | 1.21 |
Pair Trading with Axogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.Moving against Axogen Stock
| 0.9 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.83 | ELAB | Elevai Labs Common | PairCorr |
| 0.76 | VVOS | Vivos Therapeutics | PairCorr |
| 0.71 | VNRX | Volitionrx | PairCorr |
| 0.67 | FIE1 | FIELMANN AG ON | PairCorr |
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Axogen Correlation against competitors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.